![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 2, 1206-1211, January 10, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Thyroid Section, Division of Endocrinology, Diabetes and
Hypertension, Department of Medicine, Brigham and Women's Hospital
and Harvard Medical School, Boston, Massachusetts 02115
The type 3 iodothyronine selenodeiodinase (D3) is
an integral membrane protein that inactivates thyroid hormones. By
using immunofluorescence cytochemistry confocal microscopy of live or fixed cells transiently expressing FLAG-tagged human D3 or monkey hepatocarcinoma cells expressing endogenous D3, we identified D3 in the
plasma membrane. It co-localizes with Na,K-ATPase
Human Type 3 Iodothyronine Selenodeiodinase Is Located
in the Plasma Membrane and Undergoes Rapid Internalization to
Endosomes*
, with the early
endosomal marker EEA-1 and clathrin, but not with two endoplasmic
reticulum resident proteins. Most of the D3 molecule is extracellular
and can be biotinylated with a cell-impermeant probe. There is constant
internalization of D3 that is blocked by sucrose or
methyl-
-cyclodextrin-containing medium. Exposing cells to a
weak base such as primaquine increases the pool of internalized D3,
suggesting that D3 is recycled between plasma membrane and early
endosomes. Such recycling could account for the much longer half-life
of D3 (12 h) than the thyroxine activating members of the
selenodeiodinase family, type 1 (D1; 8 h) or type 2 (D2; 2 h)
deiodinase. The extracellular location of D3 gives ready access to
circulating thyroid hormones, explaining its capacity for rapid
inactivation of circulating thyroxine and triiodothyronine in patients
with hemangiomas and its blockade of the access of maternal thyroid
hormones to the human fetus.
*
This work was supported by Grants DK 36256 and DK 44128 from
the National Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: 77 Avenue Louis
Pasteur, HIM Bldg., Rm. 560, Boston, MA 02115. Tel.: 617-525-5153; Fax:
617-731-4718; E-mail: abianco@partners.org.
This article has been cited by other articles:
![]() |
G. D. V. Sagar, B. Gereben, I. Callebaut, J.-P. Mornon, A. Zeold, C. Curcio-Morelli, J. W. Harney, C. Luongo, M. A. Mulcahey, P. R. Larsen, et al. The Thyroid Hormone-Inactivating Deiodinase Functions as a Homodimer Mol. Endocrinol., June 1, 2008; 22(6): 1382 - 1393. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Anderson, A. L. Goldberg, and M. Whitman Identification of a Novel Pool of Extracellular Pro-myostatin in Skeletal Muscle J. Biol. Chem., March 14, 2008; 283(11): 7027 - 7035. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. H. Friesema, G. G. J. M. Kuiper, J. Jansen, T. J. Visser, and M. H. A. Kester Thyroid Hormone Transport by the Human Monocarboxylate Transporter 8 and Its Rate-Limiting Role in Intracellular Metabolism Mol. Endocrinol., November 1, 2006; 20(11): 2761 - 2772. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chu, R. Piper, S. Richardson, Y. Watanabe, P. Patel, and D. D. Heistad Endocytosis of Extracellular Superoxide Dismutase Into Endothelial Cells: Role of the Heparin-Binding Domain Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 1985 - 1990. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Huang, M. A. Mulcahey, A. Crescenzi, M. Chung, B. W. Kim, C. Barnes, W. Kuijt, H. Turano, J. Harney, and P. R. Larsen Transforming Growth Factor-{beta} Promotes Inactivation of Extracellular Thyroid Hormones via Transcriptional Stimulation of Type 3 Iodothyronine Deiodinase Mol. Endocrinol., December 1, 2005; 19(12): 3126 - 3136. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. McKinnon, H. Li, K. Richard, and R. Mortimer Synthesis of Thyroid Hormone Binding Proteins Transthyretin and Albumin by Human Trophoblast J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6714 - 6720. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J Beckett and J. R Arthur Selenium and endocrine systems J. Endocrinol., March 1, 2005; 184(3): 455 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. A. Gouveia, M. A. Christoffolete, C. R. Zaitune, J. M. Dora, J. W. Harney, A. L. Maia, and A. C. Bianco Type 2 Iodothyronine Selenodeiodinase Is Expressed throughout the Mouse Skeleton and in the MC3T3-E1 Mouse Osteoblastic Cell Line during Differentiation Endocrinology, January 1, 2005; 146(1): 195 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Kim, A. M. Zavacki, C. Curcio-Morelli, M. Dentice, J. W. Harney, P. R. Larsen, and A. C. Bianco Endoplasmic Reticulum-Associated Degradation of the Human Type 2 Iodothyronine Deiodinase (D2) is Mediated via an Association between Mammalian UBC7 and the Carboxyl Region of D2 Mol. Endocrinol., December 1, 2003; 17(12): 2603 - 2612. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Callebaut, C. Curcio-Morelli, J.-P. Mornon, B. Gereben, C. Buettner, S. Huang, B. Castro, T. L. Fonseca, J. W. Harney, P. R. Larsen, et al. The Iodothyronine Selenodeiodinases Are Thioredoxin-fold Family Proteins Containing a Glycoside Hydrolase Clan GH-A-like Structure J. Biol. Chem., September 19, 2003; 278(38): 36887 - 36896. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. J. M. Kuiper, W. Klootwijk, and T. J. Visser Substitution of Cysteine for Selenocysteine in the Catalytic Center of Type III Iodothyronine Deiodinase Reduces Catalytic Efficiency and Alters Substrate Preference Endocrinology, June 1, 2003; 144(6): 2505 - 2513. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |